Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,272.64 -4.87 (-0.09%) Dow
38,469.32 -217.00 (-0.56%) Nasdaq
16,799.26 +64.24 (+0.38%) Bitcoin USD
69,101.73 +1,071.16 (+1.57%) CMC Crypto 200
1,488.27 +20.34 (+1.39%)
ATXS Jul 2024 20.000 call
| Previous close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.0000 |
| Ask | 0.7500 |
| Strike | 20.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.5000 - 0.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 23 |
Business WireAstria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
BOSTON, May 30, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Jefferies Healthcare Conference on Thursday, June 6th at 10:00am ET in New York, NY.
Business WireAstria Therapeutics to Present at Upcoming Eastern Allergy Conference
BOSTON, May 24, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present final STAR-0215 Phase 1a healthy subject data in an encore presentation at the upcoming Eastern Allergy Conference in Palm Beach, Florida on June 1, 2024.
Business WireAstria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
BOSTON, May 23, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.
